These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
175 related items for PubMed ID: 20019149
1. Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations. Fothergill JL, Mowat E, Ledson MJ, Walshaw MJ, Winstanley C. J Med Microbiol; 2010 Apr; 59(Pt 4):472-481. PubMed ID: 20019149 [Abstract] [Full Text] [Related]
3. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections. Mowat E, Paterson S, Fothergill JL, Wright EA, Ledson MJ, Walshaw MJ, Brockhurst MA, Winstanley C. Am J Respir Crit Care Med; 2011 Jun 15; 183(12):1674-9. PubMed ID: 21297072 [Abstract] [Full Text] [Related]
4. Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis. Ashish A, Paterson S, Mowat E, Fothergill JL, Walshaw MJ, Winstanley C. J Cyst Fibros; 2013 Dec 15; 12(6):790-3. PubMed ID: 23642644 [Abstract] [Full Text] [Related]
5. Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections. James CE, Davies EV, Fothergill JL, Walshaw MJ, Beale CM, Brockhurst MA, Winstanley C. ISME J; 2015 Jun 15; 9(6):1391-8. PubMed ID: 25461970 [Abstract] [Full Text] [Related]
8. Genotypic and phenotypic relatedness of Pseudomonas aeruginosa isolates among the major cystic fibrosis patient cohort in Italy. Cigana C, Melotti P, Baldan R, Pedretti E, Pintani E, Iansa P, De Fino I, Favari F, Bergamini G, Tridello G, Cirillo DM, Assael BM, Bragonzi A. BMC Microbiol; 2016 Jul 11; 16(1):142. PubMed ID: 27400750 [Abstract] [Full Text] [Related]
9. Comparison of methods to test antibiotic combinations against heterogeneous populations of multiresistant Pseudomonas aeruginosa from patients with acute infective exacerbations in cystic fibrosis. Foweraker JE, Laughton CR, Brown DF, Bilton D. Antimicrob Agents Chemother; 2009 Nov 11; 53(11):4809-15. PubMed ID: 19704123 [Abstract] [Full Text] [Related]
11. Increasing resistance of the Liverpool Epidemic Strain (LES) of Pseudomonas aeruginosa (Psa) to antibiotics in cystic fibrosis (CF)--a cause for concern? Ashish A, Shaw M, Winstanley C, Ledson MJ, Walshaw MJ. J Cyst Fibros; 2012 May 11; 11(3):173-9. PubMed ID: 22146482 [Abstract] [Full Text] [Related]
12. Genetic relatedness of Pseudomonas aeruginosa isolates among a paediatric cystic fibrosis patient cohort in Ireland. Logan C, Habington A, Lennon G, Grogan J, Byrne M, O'Leary J, O'Sullivan N. J Med Microbiol; 2012 Jan 11; 61(Pt 1):64-70. PubMed ID: 21921114 [Abstract] [Full Text] [Related]
14. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection. Darch SE, McNally A, Harrison F, Corander J, Barr HL, Paszkiewicz K, Holden S, Fogarty A, Crusz SA, Diggle SP. Sci Rep; 2015 Jan 12; 5():7649. PubMed ID: 25578031 [Abstract] [Full Text] [Related]